Bermuda vs New Caledonia: Tuberculosis patients living with HIV receiving antiretroviral therapy
Bermuda
0 patients
in 2021
New Caledonia
0 patients
in 2021
Bermuda rank
141st
New Caledonia rank
141st
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Bermuda
- New Caledonia
How they compare
Bermuda currently reports 0 patients against 0 patients in New Caledonia, a difference of 0 patients.
Across all 5 years both countries report, New Caledonia has been ahead every year.
Bermuda ranks 141st and New Caledonia ranks 141st of 183 countries.
Head to head by decade
| Decade | Bermuda | New Caledonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 patients | 0 patients | 0 patients | — |
| 2010s | 0 patients | 0 patients | 0 patients | — |
| 2020s | 0 patients | 0 patients | 0 patients | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Bermuda or New Caledonia?
- Bermuda, at 0 patients against 0 patients in New Caledonia as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Bermuda and New Caledonia?
- 0 patients, with Bermuda ahead.
- How many years of comparable data are there for Bermuda and New Caledonia?
- 5 years are reported by both, from 2003 to 2021.
- How do Bermuda and New Caledonia rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Bermuda ranks 141st and New Caledonia ranks 141st of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.